PDIGREE Trial in Metastatic Untreated RCC

Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the design on the outcomes of the PDIGREE trial in metastatic, untreated renal cell carcinoma. Author: obr Added: 07/02/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts